Delivery Order SPE2DB20D2104-SPE2DB25FNBHP
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $13,967.90 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 (60-count inhalers) with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract issued on August 1, 2025, to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Trelegy Ellipta is a maintenance inhaler used for chronic obstructive pulmonary...
- The Defense Logistics Agency awarded a delivery order valued at $7,178.56 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count), with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be performed at the company's corporate office in Conshohocken, Pennsylvania. Trelegy Ellipta is a prescription maintenance inhaler used to treat chronic obstructive pulmonary...
- The Defense Logistics Agency awarded a delivery order valued at $2,284.27 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count) on July 28, 2025, with completion targeted for July 29, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Trelegy Ellipta is a combination respiratory medication used to treat chronic obstructive...
- The Defense Logistics Agency awarded a $28,030.14 delivery order to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count units) with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Trelegy Ellipta is a combination maintenance inhaler used to treat chronic obstructive pulmonary...
- The Defense Logistics Agency awarded a delivery order valued at $2,059.98 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count supply). This firm fixed price, non-competitive delivery order was issued on July 30, 2025, with an ultimate completion date of July 31, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trelegy Ellipta is a combination pharmaceutical product used in respiratory disease management,...
- The Defense Logistics Agency awarded a delivery order valued at $12,237.62 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. Trelegy Ellipta is a combination maintenance inhaler used to treat chronic obstructive...
- The Defense Logistics Agency awarded a delivery order valued at $11,129.60 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count units) on September 4, 2025, with completion scheduled for September 5, 2025. This firm fixed price delivery order was issued without a set-aside designation and reflects a competitively awarded transaction. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Trelegy Ellipta is a...
- The Defense Logistics Agency awarded a $39,507.63 firm fixed price delivery order to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count units), with an ultimate completion date of September 2, 2025. This non-set-aside competitive award was issued on August 29, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania facility. Trelegy Ellipta is a combination respiratory medication used in the treatment of chronic obstructive pulmonary disease and...
- The Defense Logistics Agency awarded a $10,547.87 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for TRELEGY ELLIPTA 100-62.5-25 inhalers (60-count). This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, due for completion by August 5, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count) on September 12, 2025, with a ceiling value of $4,687.45 and an ultimate completion date of September 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor under an existing contract vehicle. The product will be performed at AmerisourceBergen's corporate office location in...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FNBHPDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,006.08 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count) on September 23, 2025, with an ultimate completion date of September 24, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Trelegy Ellipta is a combination respiratory medication used for chronic obstructive pulmonary disease management, reflecting the Defense Logistics Agency Medical Supply Chain's ongoing need for pharmaceutical products supporting military and veteran healthcare systems. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply an extensive range of medications, vaccines, medical devices, and healthcare commodities to support military healthcare programs worldwide. The company's demonstrated capability to fulfill federal medical procurement requirements through competitive awards positions it as a critical vendor within the Defense Logistics Agency's pharmaceutical procurement strategy, particularly as the agency develops next-generation Pharmaceutical Prime Vendor Global Program contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 9/23/25 |